Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Clinical trial NCT00611351 · COMPLETED

Trial details

NCT number: NCT00611351
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Secondary Myelofibrosis

Start date: 2005-06-07
Primary completion: 2008-02-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.